Hspb5 — Heat Shock Protein Beta 5 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
HSPB5 Gene
| Property | Value |
|----------|-------|
| **Gene Symbol** | HSPB5 |
| **Full Name** | Heat Shock Protein Family B (Small) Member 5 (Alpha B-Crystallin) |
| **Chromosomal Location** | 11q23.1 |
| **NCBI Gene ID** | 9369 |
| **OMIM ID** | 123610 |
| **Ensembl ID** | ENSG00000120063 |
| **UniProt ID** | P02511 |
| **Associated Diseases** | Alexander Disease, Retinitis Pigmentosa, Cataract, Myopathy |
HSPB5 (Heat Shock Protein Family B Member 5), also known as alpha B-crystallin (CRYAB), is a small heat shock protein with molecular chaperone activity. It was originally identified as a major lens protein (crystallin) and is now recognized as an important cytoskeletal protector in multiple tissues, including the heart, skeletal muscle, and brain. Mutations in HSPB5 cause Alexander disease, and the protein is implicated in various neurodegenerative conditions due to its anti-aggregation and protective functions.
HSPB5 functions as:
- Molecular chaperone: Prevents protein aggregation under stress
- Cytoskeletal stabilizer: Protects intermediate filaments
- Anti-apoptotic protein: Blocks caspase activation
- Stress response protein: Rapidly induced by heat and oxidative stress
HSPB5 prevents aggregation by:
- Binding to denatured proteins: Formation of stable complexes
- Holding substrate proteins: Preventing irreversible aggregation
- Facilitating refolding: Working with Hsp70 system
- Disaggregase activity: Recent findings show direct disaggregation
HSPB5 preferentially binds:
- Intermediate filaments: Vimentin, desmin, GFAP
- Z Proteins: Z-disc components in muscle
- Crystallins: Other lens proteins
- Apoptotic proteins: Bcl-2 family members
The HSPB5 gene is located on chromosome 11q23.1 and encodes a 175-amino acid protein. The gene contains three exons and is highly conserved across species.
HSPB5 contains:
- N-terminal domain: Variable region with phosphorylation sites
- Alpha-crystallin domain: ~90 aa conserved region (aa 60-150)
- C-terminal extension: Hydrophilic tail for solubility
- Oligomerization interface: Forms large multimeric complexes
¶ Alexander Disease
HSPB5 mutations cause Alexander disease:
- Gain of toxicity: Mutant protein forms Rosenthal fibers
- GFAP inclusion bodies: Characteristic astrocyte pathology
- Leukodystrophy: White matter destruction
- Neurological symptoms: Developmental regression, seizures
HSPB5 in retinal disease:
- Photoreceptor protection: Essential for retina function
- Mutations cause RP: Autosomal dominant inheritance
- Mechanism: Impaired chaperone function
- Therapeutic approaches: Gene therapy strategies
HSPB5 in lens:
- Major crystallin: ~30% of lens protein composition
- Transparency maintenance: Prevents light scattering
- Age-related changes: Modified in age-related cataract
- Post-translational modifications: Glycation, oxidation
HSPB5 is expressed in:
- Lens: Very high expression, major crystallin
- Heart: High expression, cardiac protection
- Skeletal muscle: Abundant in fast fibers
- Brain: Astrocytes, neurons
- Kidney, lung, liver: Lower expression
| Strategy |
Approach |
Status |
Notes |
| Gene therapy |
AAV-CRYAB |
Preclinical |
Cardiac protection |
| Small molecules |
Pharmacological chaperones |
Discovery |
For Alexander disease |
| Protein therapy |
Recombinant HSPB5 |
Research |
Protein delivery |
| Gene editing |
CRISPR approaches |
Discovery |
Correct mutations |
- Mechanism elucidation: Understanding oligomer dynamics
- Drug discovery: Small molecule chaperone activators
- Gene therapy: Safe and effective delivery systems
- Biomarker: HSPB5 as stress/damage marker
- Aging studies: Role in age-related diseases
The study of Hspb5 — Heat Shock Protein Beta 5 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Goldstein LE, et al. "Alpha-crystallin in age-related disease." Exp Eye Res 2022.
- Iwaki T, et al. "Alexander disease and HSPB5 mutations." Brain Dev 2021.
- Arrigo AP, et al. "Small heat shock proteins in stress response." Cell Stress Chaperones 2020.
4.ECHM. "HSPB5 mutations and retinitis pigmentosa." Ophthalmology 2019.
- Veena S, et al. "Alpha B-crystallin as therapeutic target." J Mol Neurosci 2018.